- Home
- FE vs WST Comparison
FE vs WST Comparison
Compare FE & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FE
- WST
- Stock Information
- Founded
- FE 1996
- WST 1923
- Country
- FE United States
- WST United States
- Employees
- FE N/A
- WST N/A
- Industry
- FE Electric Utilities: Central
- WST Medical/Dental Instruments
- Sector
- FE Utilities
- WST Health Care
- Exchange
- FE Nasdaq
- WST Nasdaq
- Market Cap
- FE N/A
- WST 15.6B
- IPO Year
- FE N/A
- WST N/A
- Fundamental
- Price
- FE $40.52
- WST $227.12
- Analyst Decision
- FE Buy
- WST Buy
- Analyst Count
- FE 15
- WST 7
- Target Price
- FE $46.15
- WST $331.67
- AVG Volume (30 Days)
- FE 4.5M
- WST 646.1K
- Earning Date
- FE 07-30-2025
- WST 07-24-2025
- Dividend Yield
- FE 4.39%
- WST 0.37%
- EPS Growth
- FE 1.45
- WST N/A
- EPS
- FE 1.88
- WST 6.37
- Revenue
- FE $13,764,000,000.00
- WST $2,895,800,000.00
- Revenue This Year
- FE $9.20
- WST $3.38
- Revenue Next Year
- FE $3.82
- WST $5.85
- P/E Ratio
- FE $21.54
- WST $35.63
- Revenue Growth
- FE 8.03
- WST N/A
- 52 Week Low
- FE $37.58
- WST $187.43
- 52 Week High
- FE $44.97
- WST $352.33
- Technical
- Relative Strength Index (RSI)
- FE 50.10
- WST 59.84
- Support Level
- FE $39.34
- WST $219.60
- Resistance Level
- FE $40.59
- WST $233.84
- Average True Range (ATR)
- FE 0.53
- WST 5.29
- MACD
- FE 0.11
- WST 0.60
- Stochastic Oscillator
- FE 76.08
- WST 66.82
About WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.